2024 FUTURES – Therapies to Preserve and Protect Muscle

Presentations covering therapies aiming to preserve and protect muscle in Duchenne, including anti-inflammatory agents, muscle stabilizers, and other mechanisms with relevant updates from companies in the space.


Karyn Koladicz, MD

Executive Medical Director for Medical Affairs, Neurology PTC Therapeutics

Lianna Orlando, PhD

Senior Director of Research


Abby Bronson

Vice President, Patient Advocacy & External Innovation

Edgewise Therapeutics

Stanley Iyadurai, MD, PhD

Sr VP Medical Affairs and Drug Discovery


Scott Baver, PhD

Head of Medical Affairs

ITF Therapeutics

Mark Awadalla

Vice President of Clinical Operations


Related Resources

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.